The reduced cellular growth caused by ERK1/2 transduction could be a growth-limiting factor in the early phase of tumor expansion and therefore a reason for the downregulation of ERK1/2 phosphorylation in colon adenomas. Here, MAPK3 is linked to neoplasm.